(Q42474246)

1 November 2017

In vivo brain myo-inositol levels in children with Down syndrome (English)

1 reference

1 November 2017

Berry GT

1

1 reference

1 November 2017

Wang ZJ

2

1 reference

1 November 2017

Dreha SF

3

1 reference

1 November 2017

Finucane BM

4

1 reference

1 November 2017

Zimmerman RA

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

The Journal of Pediatrics

1 November 2017

1 reference

1 November 2017

135

1 reference

1 November 2017

1

1 reference

1 November 2017

94-97

1 reference

Down's syndrome fibroblasts exhibit enhanced inositol uptake

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

The 21q22.1 STS marker, VN02 (EST00541 cDNA), is part of the 3' sequence of the human Na+/myo-inositol cotransporter (SLC5A3) gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

The structural organization of the human Na+/myo-inositol cotransporter (SLC5A3) gene and characterization of the promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

Transcription of the sodium/myo-inositol cotransporter gene is regulated by multiple tonicity-responsive enhancers spread over 50 kilobase pairs in the 5'-flanking region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

Inositol phosphates and cell signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

The molecular heterogeneity of protein kinase C and its implications for cellular regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

Signalling through the lipid products of phosphoinositide-3-OH kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

Brief report: organic osmolytes in the brain of an infant with hypernatremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

myo-inositol: a newly identified nonnitrogenous osmoregulatory molecule in mammalian brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

Role of increased cerebral myo-inositol in the dementia of Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

Localized proton magnetic resonance spectroscopy of cerebral metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

Brain accumulation of myo-inositol in the trisomy 16 mouse, an animal model of Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

Application of stable isotope tracer combined with mass spectrometric detection for studying myo-inositol uptake by cultured neurons from fetal mouse: effect of trisomy 16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

Polyol profiles in Down syndrome. myo-Inositol, specifically, is elevated in the cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970334-3

10.1016/S0022-3476(99)70334-3

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference